NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

Recent signs point to something significantly different, IMO.
1. "coming weeks" comment at ASCO...although delayed to date

2. Forced Conversion of preferred, generally done to align all shares into the same class for valuation and purchase/transfer

3. Two trials scheduled to start this Fall and now pushed back. I don't believe it is due to lack of funds as the partners in these trials are participating and funding. I believe that starting the trials would complicate a sale of the company if the participants were not the buyers, thus leaving them in a partner trial with the competition.

4. Angel financing by Bigger and ohters with unique 4 month out clause.

5. NT 10-Q. Reads like LP was very close to a deal prior to data presentation at SNO. Once new data out, LP likely had more to bargain with and to renegotiate.

6. SNO data refresh by Linda Liau. Powerful. Statistically significant, and long tail.

7. LP signals 4 part process to end trial with Lock, scrub, unblinding.

8. Option realignment for officers. Again, part of the original company plan but doing it now may have additional relevance.

9. Deal Announcement "imminent" IMO....